ONCOCYTE CORP

CUSIP: 68235C107 Class: COM

Defender Capital, LLC.'s Holding History (CIK: 0001766929)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 44,378 Value ($000) $127 Avg Close — Range —
Q4 2024
Shares 47,078 Value ($000) $112 Avg Close — Range —
Q3 2024
Shares 59,353 Value ($000) $169 Avg Close — Range —
Q2 2024
Shares 55,220 Value ($000) $163 Avg Close — Range —
Q1 2024
Shares 55,885 Value ($000) $164 Avg Close — Range —
Q4 2023
Shares 71,650 Value ($000) $179 Avg Close — Range —
Q3 2023
Shares 114,520 Value ($000) $357 Avg Close — Range —
Q2 2023
Shares 2,327,930 Value ($000) $535 Avg Close — Range —
Q1 2023
Shares 2,363,430 Value ($000) $838 Avg Close — Range —
Q4 2022
Shares 2,272,930 Value ($000) $729 Avg Close — Range —
Q3 2022
Shares 2,551,980 Value ($000) $1,883 Avg Close — Range —
Q2 2022
Shares 2,589,380 Value ($000) $2,330 Avg Close — Range —
Q1 2022
Shares 2,562,130 Value ($000) $4,001 Avg Close — Range —
Q4 2021
Shares 2,216,800 Value ($000) $4,811 Avg Close — Range —
Q3 2021
Shares 1,960,820 Value ($000) $6,935 Avg Close — Range —
Q2 2021
Shares 1,347,200 Value ($000) $7,732 Avg Close — Range —
Q1 2021
Shares 604,450 Value ($000) $3,122 Avg Close — Range —